Anti-EGFR Monoclonal Antibodies plus Chemotherapy in the First-Line Treatment of Advanced NSCLC: A Meta-Analysis

被引：0
|
作者：
Stock, Gustavo [1 ]
Aguiar, Pedro, Jr. [1 ]
Santoro, Ilka [1 ]
Tadokoro, Hakaru [1 ]
De Mello, Ramon [2 ]
Lopes, Gilberto [3 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Univ Algarve, Faro, Portugal
[3] HCOR Canc Ctr, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
anti-EGFR; biomarker; Targeted therapy; Individual Medicine;
D O I：
10.1016/j.jtho.2016.11.360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA23.01
引用
收藏
页码：S333 / S334
页数：2
相关论文
共 50 条
  • [31] The impact of anti-EGFR therapy when added to first-line standard platinum- gemcitabine chemotherapy in advanced biliary tract cancers: A meta-analysis of randomized studies
    Findakly, Dawood
    Haddad, Philip A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC
    Fiala, O.
    Pesek, M.
    Finek, J.
    Benesova, L.
    Bortlicek, Z.
    Minarik, M.
    NEOPLASMA, 2013, 60 (04) : 425 - 431
  • [33] Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies
    Zhang, Wu
    Gordon, Michael
    Lenz, Heinz-Josef
    ANNALS OF MEDICINE, 2006, 38 (08) : 545 - 551
  • [34] Anti-EGFR monoclonal antibodies in lung cancer treatment
    Schiller, Joan H.
    LANCET ONCOLOGY, 2015, 16 (07): : 738 - 739
  • [35] Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced NSCLC
    Li, Jiahao
    Zhang, Tiantian
    Xu, Yongmei
    Lu, Peiyao
    Zhu, Jiaxin
    Liang, Wenhua
    Jiang, Jie
    IMMUNOTHERAPY, 2020, 12 (14) : 1067 - 1075
  • [36] Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
    Shao, Taihang
    Ren, Yinan
    Zhao, Mingye
    Tang, Wenxi
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [37] Anti-EGFR therapy in first-line colorectal cancer
    Lamas, Maria J.
    Duran, Goretti
    Gallardo, Elena
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1499 - 1503
  • [38] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment:a meta-analysis
    Wei-Dong Shen
    Hong-Lin Chen
    Peng-Fei Liu
    Chinese Journal of Cancer Research, 2014, 26 (01) : 59 - 71
  • [39] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis
    Shen, Wei-Dong
    Chen, Hong-Lin
    Liu, Peng-Fei
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : 59 - 71
  • [40] Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doublet
    Hsieh, Yao-Yu
    Su, Yu-Li
    Kuan, Feng-Che
    Chen, Shu-Chuan Grace
    Chang, Chia-Lun
    Shao, Yu-Yun
    Tsai, Ching-Wen
    Liang, Yi-Hsin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (12): : 5909 - 5920
12345